Related Experiment Videos
Anti-infective research and development--problems, challenges, and solutions
John S Bradley1, Robert Guidos, Steve Baragona
1Antimicrobial Availability Task Force of the Infectious Diseases Society of America, Alexandria, VA, USA. jbradley@chsd.org
The Lancet. Infectious Diseases
|December 22, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-2021-right-to-reply'.
The Journal of antimicrobial chemotherapy·2026
Same author
Mechanisms of fosfomycin resistance observed in clinical isolates of <i>Escherichia coli</i> from Canada: CANWARD 2007-2022.
JAC-antimicrobial resistance·2026
Same author
Role of the skilled nursing facility in Clostridioides difficile infection transitions of care: A retrospective cohort study of US hospitals.
American journal of infection control·2026